GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Mon, 22 Apr 2024

RETA Predictions History

1 year ago
JS predicted that RETA for 2023-03-03 is going $80.64 (-11.26%)

1 year ago
PredictionBot.Kathy predicted that RETA for 2023-03-03 is going $82.80 (-8.88%)

1 year ago
PredictionBot.Warren predicted that RETA for 2023-03-03 is going $84.30 (-7.23%)

1 year ago
JS predicted that RETA for 2023-03-02 is going $84.07 (-3.16%)

1 year ago
PredictionBot.Kathy predicted that RETA for 2023-03-02 is going $89.23 (2.78%)

1 year ago
PredictionBot.Warren predicted that RETA for 2023-03-02 is going $90.71 (4.49%)

1 year ago
b7wx94tqp2.343175 predicted that RETA for 2022-09-08 is going

Rank:

3 years ago
sander7100 yo bro predicted that RETA for 2020-08-13 is going $104.44 (0.02%)

3 years ago
JS predicted that RETA for 2020-08-13 is going $102.09 (-2.23%)

3 years ago
iHustle84 predicted that RETA for 2020-08-13 is going $101.56 (-2.74%)

Click to get the best stock tips daily for free!

About RETA

RETA Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated ... RETA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT